The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of nintedanib in patients with recurrent or metastatic salivary gland cancer: A multicenter phase II study.
 
Youjin Kim
No Relationships to Disclose
 
Su Jin Lee
No Relationships to Disclose
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Hanmi; Kyowa Hakko Kirin; Lilly; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca
 
Se-hoon Lee
No Relationships to Disclose
 
Jong Mu Sun
No Relationships to Disclose
 
Bhumsuk Keam
No Relationships to Disclose
 
Ho Jung An
No Relationships to Disclose
 
Jae Yong Cho
No Relationships to Disclose
 
Jin-Soo Kim
No Relationships to Disclose
 
Ha-young Lee
No Relationships to Disclose
 
HyeRyun Kim
No Relationships to Disclose
 
Kyoung Eun Lee
No Relationships to Disclose
 
Moon Young Choi
No Relationships to Disclose
 
Ki Hyeong Lee
No Relationships to Disclose
 
Myung-Ju Ahn
No Relationships to Disclose